Therapy of congenital cytomegalovirus infection in children
In 90% of children congenital cytomegalovirus infection (CMV) proceeds latently. However, there is a high risk of developing severe clinical manifestations in the postnatal period. Since recombinant interferon drugs successfully used in obstetric practice for the prevention of vertical transmission...
Main Authors: | T. M. Chernova, E. V. Baracina, R. Z. Zarkua |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2016-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1261 |
Similar Items
-
PARAMETERS OF ANTIVIRAL IMMUNITY IN NEWBORNS WITH CYTOMEGALOVIRUS INFECTION IN CASES OF LATE DETECTION OF CYTOMEGALOVIRUS DNA
by: L. V. Kravchenko
Published: (2018-09-01) -
Challenging problems of congenital cytomegalovirus infection therapy: case study
by: N. V. Rymarenko, et al.
Published: (2024-01-01) -
Congenital cytomegalovirus infection
by: Katarina Rednak-Paradiž, et al.
Published: (2006-11-01) -
The problem of congenital cytomegalovirus infection
by: R. A. Ivanova, et al.
Published: (2016-07-01) -
Congenital cytomegalovirus infection: ICCRG guidelines and management aspects that are at the stage of clinical trials
by: O.L. Logvinova, et al.
Published: (2018-03-01)